Key statistics
On Tuesday, Evolus Inc (0K16:LSE) closed at 16.53, -6.48% below its 52-week high of 17.67, set on Sep 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 16.53 |
Low | 16.53 |
Bid | -- |
Offer | -- |
Previous close | 16.00 |
Average volume | 577.11 |
---|---|
Shares outstanding | 63.09m |
Free float | 49.55m |
P/E (TTM) | -- |
Market cap | 1.04bn USD |
EPS (TTM) | -0.9073 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 17:37 BST.
More ▼
Press releases
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
- Evolus to Hold Investor Day on September 12, 2024
- Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia
- Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Evolus to Report Second Quarter Financial Results on July 31, 2024
More ▼